Teva Exits Astellas Patent Suit Over Cancer Drug

By Pete Brush (March 17, 2011, 12:12 PM EDT) -- Astellas Pharma Inc. unit OSI Pharmaceuticals Inc., Genentech Inc. and Pfizer Inc. settled their infringement suit over generic versions of the cancer treatment Tarceva with Teva Pharmaceuticals USA Inc. in Delaware on Tuesday, leaving Mylan Pharmaceuticals Inc. as the sole defendant in the litigation....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!